Our meta-analysis was based on thirteen studies with 2,363 patients with T2DM and 4,650 healthy controls evaluating the association between the MCP-1 rs1024611 polymorphism and T2DM risk. This evidence concerns the gene CCL2 and type 2 diabetes mellitus.